Welcome to our dedicated page for BARCLAYS BANK PLC SEC filings (Ticker: VXZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BARCLAYS BANK PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BARCLAYS BANK PLC's regulatory disclosures and financial reporting.
Barclays Bank PLC has issued $1.2 million in Buffered Autocallable Contingent Coupon Notes due June 25, 2030, linked to the performance of three ETFs: iShares Russell 2000 ETF, Health Care Select Sector SPDR Fund, and Materials Select Sector SPDR Fund.
Key features include:
- $1,000 minimum denomination with 9% per annum contingent coupon rate ($7.50 per quarter)
- Automatic call feature activates after first year if all reference assets close at or above their call values
- 15% downside buffer protection at maturity
- Potential loss of up to 100% of principal if least performing asset falls below buffer value
The notes include a U.K. Bail-in Power provision allowing authorities to write-down, convert, or modify the terms in a resolution scenario. Initial estimated value is $971.10 per note, below the issue price of $1,000. Barclays Capital receives a 0.60% commission.